[2-[tert-butyl-[(2S)-2-[2-[3-(butylamino)-4-phenoxy-5-sulfamoylbenzoyl]oxyacetyl]oxy-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propyl]amino]-2-oxoethyl] 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate
C51H64N8O15S3 — CID 155795942
Data last refreshed: (MolForge compound catalog, from PubChem)
About [2-[tert-butyl-[(2S)-2-[2-[3-(butylamino)-4-phenoxy-5-sulfamoylbenzoyl]oxyacetyl]oxy-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propyl]amino]-2-oxoethyl] 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate
[2-[tert-butyl-[(2S)-2-[2-[3-(butylamino)-4-phenoxy-5-sulfamoylbenzoyl]oxyacetyl]oxy-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propyl]amino]-2-oxoethyl] 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate (PubChem CID 155795942) has the molecular formula C51H64N8O15S3 and a molecular weight of 1125.31 g/mol. Its IUPAC name is [2-[tert-butyl-[(2S)-2-[2-[3-(butylamino)-4-phenoxy-5-sulfamoylbenzoyl]oxyacetyl]oxy-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propyl]amino]-2-oxoethyl] 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate.
Molecular Properties
| Compound Name | [2-[tert-butyl-[(2S)-2-[2-[3-(butylamino)-4-phenoxy-5-sulfamoylbenzoyl]oxyacetyl]oxy-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propyl]amino]-2-oxoethyl] 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate |
|---|---|
| PubChem CID | 155795942 |
| Molecular Formula | C51H64N8O15S3 |
| Molecular Weight | 1125.31 g/mol |
| Exact Mass | 1124.37 |
| IUPAC Name | [2-[tert-butyl-[(2S)-2-[2-[3-(butylamino)-4-phenoxy-5-sulfamoylbenzoyl]oxyacetyl]oxy-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propyl]amino]-2-oxoethyl] 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate |
| SMILES | CCCCNc1cc(C(=O)OCC(=O)O[C@H](COc2nsnc2N2CCOCC2)CN(C(=O)COC(=O)c2cc(NCCCC)c(Oc3ccccc3)c(S(N)(=O)=O)c2)C(C)(C)C)cc(S(N)(=O)=O)c1Oc1ccccc1 |
| InChI | InChI=1S/C51H64N8O15S3/c1-6-8-20-54-39-26-34(28-41(76(52,64)65)45(39)73-36-16-12-10-13-17-36)49(62)70-32-43(60)59(51(3,4)5)30-38(31-69-48-47(56-75-57-48)58-22-24-68-25-23-58)72-44(61)33-71-50(63)35-27-40(55-21-9-7-2)46(42(29-35)77(53,66)67)74-37-18-14-11-15-19-37/h10-19,26-29,38,54-55H,6-9,20-25,30-33H2,1-5H3,(H2,52,64,65)(H2,53,66,67)/t38-/m0/s1 |
| InChIKey | AKYXIDYJVSLOCT-LHEWISCISA-N |
| XLogP | 6.31 |
| TPSA | 309.53 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 77 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1125.31 |
| LogP ≤ 5 | 6.31 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 21 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155795942 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.